Maryland State Retirement & Pension System Sells 2,392 Shares of Colgate-Palmolive (NYSE:CL)

Maryland State Retirement & Pension System lowered its holdings in shares of Colgate-Palmolive (NYSE:CL) by 5.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,042 shares of the company’s stock after selling 2,392 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Colgate-Palmolive were worth $4,004,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Axxcess Wealth Management LLC grew its position in Colgate-Palmolive by 0.3% in the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock worth $3,526,000 after acquiring an additional 117 shares in the last quarter. Commonwealth Financial Services LLC boosted its holdings in shares of Colgate-Palmolive by 4.5% in the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock worth $247,000 after purchasing an additional 118 shares during the period. D Orazio & Associates Inc. increased its position in shares of Colgate-Palmolive by 4.2% during the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company’s stock valued at $271,000 after purchasing an additional 120 shares during the last quarter. Lantz Financial LLC raised its holdings in Colgate-Palmolive by 0.6% during the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after buying an additional 122 shares during the period. Finally, Horizon Kinetics Asset Management LLC lifted its position in Colgate-Palmolive by 4.2% in the third quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock worth $322,000 after buying an additional 124 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 1.1 %

Shares of NYSE CL opened at $90.44 on Thursday. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The stock’s fifty day simple moving average is $89.19 and its two-hundred day simple moving average is $94.41. The stock has a market capitalization of $73.39 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company earned $0.87 EPS. As a group, analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Barclays reduced their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a research note on Friday, March 14th. Finally, Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.